<img alt="" height="1" width="1" />
FDA expands Pfizer drug approval for rare cancer
BusinessWeek
The Food and Drug Administration said Friday it expanded approval of a Pfizer drug to treat a rare form of pancreatic cancer. The agency said it cleared Sutent to treat cancerous tumors of the pancreas that cannot be surgically removed, or have spread ...
Pfizer Drug Wins OK for Jobs's Type of CancerBloomberg
FDA Approves Sunitinib for Pancreatic Neuroendocrine TumorsMedscape
Pfizer Says Sutent Approved By FDA To Treat Pancreatic NET - UpdateRTT News
USA Market News -San Francisco Chronicle -MedPage Today
all 76 news articles »
More...